Turkey Drafts New Law: Sellers of E-Cigarettes Could Face Up to 6 Years in Prison

Dec.02.2024
Turkey Drafts New Law: Sellers of E-Cigarettes Could Face Up to 6 Years in Prison
The Turkish government is tightening regulations on e-cigarettes, with a new bill proposing severe penalties for sellers, including up to six years in prison for violators.

The Turkish government has decided to tighten regulations on tobacco and alcohol, introducing severe penalties for those involved in the sale of e-cigarettes and alcohol. The new legislation, aimed at curbing illegal trade and protecting public health, will soon be presented to Parliament for review, according to a report by Haberler on December 1st.

 

According to the new draft law:

 

  • Those involved in the production, sale, possession, and transportation of electronic cigarettes and electronic shishas (hookahs), as well as their components, such as devices, parts, and solutions, will face imprisonment from 3 to 6 years. 

 

  • Cigarette paper and cigarette filters must bear warning labels with 85% of the surface covered with images and Turkish text. Violators will face fines of 50,000 Turkish Lira (approximately $1,440).

 

  • Sellers who provide tobacco or shisha to minors under 18 years old and commit the same offense three times within five years will have their sales or presentation licenses revoked, and their businesses will be closed for two years.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

BAT Japan to set up a VELO special booth at an outdoor culture market, showcasing a product launched on Feb. 2
BAT Japan to set up a VELO special booth at an outdoor culture market, showcasing a product launched on Feb. 2
BAT Japan announced it will support and sponsor the outdoor culture market “DIGGIN DEEP 2026 DAIKANYAMA,” held on March 7 and 8, 2026 at Daikanyama T-SITE, and will set up a special booth for the oral tobacco brand VELO at the venue. The booth will feature product displays and trial experiences, including the new product Velo Smooth Peppermint Medium, which went on sale on Feb. 2.
Mar.05 by 2FIRSTS.ai
Global Forum on Nicotine 2026 to explore why prohibition of safer nicotine products risks, and does not protect, public health
Global Forum on Nicotine 2026 to explore why prohibition of safer nicotine products risks, and does not protect, public health
Mar.12
KT&G to cancel 10.866 mln treasury shares, about 9.5% of shares outstanding
KT&G to cancel 10.866 mln treasury shares, about 9.5% of shares outstanding
KT&G said it plans to cancel all treasury shares it holds, totaling 10,866,189 shares, representing about 9.5% of shares outstanding, in line with Korea’s third amendment to the Commercial Act requiring companies to cancel repurchased shares within one year. The company also disclosed progress on its shareholder-return plan and multiple agenda items for next month’s shareholders meeting.
Feb.26
Deputy Mikhail Ivanov delivers a lesson on the harms of vapes to Sormovo school students
Deputy Mikhail Ivanov delivers a lesson on the harms of vapes to Sormovo school students
According to the United Russia Nizhny Novgorod branch website, Nizhny Novgorod City Duma deputy chair Mikhail Ivanov (Mikhail Ivanov) spoke to students at School No. 78 about the harms of vapes, electronic nicotine delivery systems and nicotine-free liquids, stressing that such topics should be discussed with children “honestly” and “only with facts.”
Feb.28 by 2FIRSTS.ai
Alan Zhao: What the Rise of Nicotine Pouches Means for Tobacco Retailers
Alan Zhao: What the Rise of Nicotine Pouches Means for Tobacco Retailers
Alan Zhao argues that nicotine pouches are no longer a niche alternative, but a force quietly reshaping the future of tobacco retail. For distributors and retailers, the real risk is not missing a trend—it is moving too late, after regulation tightens, shelf space hardens and the market begins to choose its winners.
Mar.31 by Alan Zhao | 2Firsts Perspectives
Small ENDS Manufacturers Press FDA on Abuse Liability Standards as Agency Defines Pharmacological Review Framework
Small ENDS Manufacturers Press FDA on Abuse Liability Standards as Agency Defines Pharmacological Review Framework
At the third session of its PMTA roundtable, the FDA outlined its framework for assessing abuse liability in ENDS products, emphasizing the role of nicotine pharmacokinetics and product-specific data in APPH determinations. Small manufacturers questioned the high cost of clinical PK studies and the absence of defined numeric thresholds, while raising bridging strategies and PBPK modeling as potential alternatives.
Feb.11